Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis

International Journal of Cancer

Volumn 69, Issue 6, 1996, Pages 445-447

  Jahkola, Tiina ^a   Toivonen, Terttu ^b   Von Smitten, Karl ^a   Blomqvist, Carl ^a   Virtanen, Ismo ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Maria Hospital   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TENASCIN;

ARTICLE; BREAST CANCER; CANCER INVASION; EARLY CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; RISK FACTOR;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; TENASCIN;

EID: 0030476255     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961220)69:6<445::AID-IJC4>3.0.CO;2-4     Document Type: Article

References (14)

1. CHIQUET-EHRISMANN, R., HAGIOS, C. and SCHENK, S., The complexity in regulating the expression of tenascins. BioEssays, 7, 873-878 (1995).
2. EBCTCG, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group (see Comments). Lancet, 339, 71-85 (1992).
3. ERICKSON, H.P., Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol., 5, 869-876 (1993).
4. FERGUSON, J.E., SCHOR, A.M., HOWELL, A. and FERGUSON, M.W., Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. Differentiation, 42, 199-207 (1990).
5. HOWEEDY, A.A., VIRTANEN, I., LAITINEN, L., GOULD, N.S., KOUKOULIS, G.K. and GOULD, V.E., Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab. Invest., 63, 798-806 (1990).
6. KOUKOULIS, O.K., GOULD, V.E., BHATTACHARYYA, A., GOULD, J.E., HOWEEDY, A.A. and VIRTANEN, I., Tenascin in normal, reactive, hyperplastic and neoplastic tissues: biologic and pathologic implications. Hum. Pathol, 22, 636-643 (1991).
7. MACKIE, E.J., CHIQUET, E.R., PEARSON, C.A., INAGUMA, Y., TAYA, K., KAWARADA, Y. and TAKAKURA, T., Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. nat. Acad. Sci. (Wash.), 84, 4621-4625 (1987).
8. MOCH, H., TORHORST, J., DURMULLER, U., FEICHTER, G.E., SAUTER, G. and GUDAT, F., Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer. Pathol. Res. Pract, 189, 510-514 (1993).
9. NATALI, P.G., NICOTRA, M.R., BIGOTTI, A., BOTTI, C., CASTELLANI, P., RISSO, A.M. and ZARDI, L., Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int. J. Cancer, 47, 811-816 (1991).
10. RÜEGG, C.R., CHIQUET-EHRISMANN, R. and ALKAN, S.S., Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc. nat. Acad. Sci. (Wash.), 86, 7437-7441 (1989).
11. SAKAKURA, T. and KUSAKABE, M., Can tenascin be redundant in cancer development? Perspect. Devel. Neurobiol., 2, 111-116 (1994).
12. SHOJI,T., KAMIYA, T., TSUBURA, A., HAMADA, Y., HATANO, T., HIOKI, K. and MORII, S., Tenascin staining positivity and the survival of patients with invasive breast carcinoma. J. surg. Res., 55, 295-297 (1993).
13. THTTA, O., WAHLSTRÖM, T., PAAVONEN, J., LINNALA, A., SHARMA, S., GOULD, V.E. and VIRTANEN, I., Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Amer. J. Pathol., 141, 907-913 (1992).
14. YOSHIDA, T., ISHIHARA, A., HIROKAWA, Y., KUSAKABE, M. and SAKAKURA, T., Tenascin in breast cancer development - is epithelial tenascin a marker for poor prognosis? Cancer Lett., 90, 65-73 (1995).